Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific, Invitrogen, Syngen, AnaSpec

Thermo Fisher Scientific unveiled version 8.0 of the Nautilus laboratory information management system this week. The company said the update is the most comprehensive to Nautilus since the product was commercialized in 1998.
Among the improvements, according to Thermo Fisher, is greater ease of use from organizing data to searching and log-in; a new cut-and-paste operation allowing users to copy workflow nodes rather than having to rebuild them; and the use of .NET technology that gives users greater interaction and flexibility with plates.

Invitrogen this week launched its ProtoArray Human Protein Microarray version 4.0. The array “enables customers to screen biological samples or labeled probe of interest against 8,000 unique human proteins in a single, rapid experiment,” the company said in a statement. 

Syngene this week introduced Dyversity 4, an automated multifunctional image analyzer. The instrument comprises a high resolution, 16-bit CCD camera inside a light tight darkroom integrated to a PC containing Syngene image capture and analysis software, the company said in a statement.

AnaSpec launched this week 11 research-ready plant peptides called phytochelatins, a class of heavy metal-detoxifying peptides. More information about them can be found here.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.